TOGETHER, WE'VE GOT THIS.
LabCorp has announced that Covance has completed the transaction to acquire GlobalCare, a globally recognized industry leader in patient-centric decentralized clinical trials (DCTs). The acquisition of GlobalCare will expand the Covance DCTs offering into global markets and help us meet your growing demand for patient-centric trial designs.Read More
DECENTRALIZED CLINICAL TRIALS
Covance has reimagined clinical research by developing a highly patient-centric approach to study design and execution. This approach blends a global patient support ecosystem with technology to allow patients to participate in clinical research from virtually anywhere.Read More
We’re in this together
Whether you are developing a COVID-19 assay, a vaccine to prevent patients from getting COVID-19, an antiviral or a treatment to mitigate the severe immunological response (cytokine storm) associated with COVID-19, we can partner with you to provide critical drug development and diagnostic services to address the global pandemic.Read More
The healthcare industry is always looking to the future... to discover a better treatment... to deliver a cure... to prevent disease…to improve quality of life. And it’s our mission to help speed that process. What matters is not “how it’s always been done,” but how it can be done now. Better. And Faster. Through new approaches explored, ideas perfected, and transformational thinking.Read More
Covance, the drug development business of LabCorp, is recognized as a leader in drug development because of our exceptional people. We embrace and celebrate the different strengths, experiences and perspectives of our 65,000+ enterprise team members across the globe. Our team is driven by an energizing purpose to improve health and improve lives. Here, you can play a role in bringing new scientific discoveries to life and make a difference in the lives of millions. Join us and discover your extraordinary potential.
Visit the Knowledge Library to learn more about our industry.